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Abstract 
Background: Congenital malformations (CMs) are structural and functional anomalies that have a significant but 
under-recognized cause of mortality and morbidity among infants and children under 5 years of age. CMs are not 
only life threatening, but also result in long-term disabilities that negatively affect individuals, families, health care 
systems and societies.  
Objectives: The purpose of this study was to describe the prevalence and outcomes of birth defects in newborns of 
South Wollo and Oromia zones of Amhara regional state.  
Methods: A retrospective cross-sectional study was done in three hospitals of South Wollo and Oromia zones, 
where 22,624 infants were born between January 2015 and December 2017. The presence and type of birth defects 
in the infants, as well as their outcomes, were identified by reviewing the medical records of their mothers. 
Medical records with incomplete information were excluded from the study. The data were collected using a pre-
tested checklist for data collection.  
Results: A total of 22,624 infants were born during the study period. Three hundred and twenty-four (1.43%) 
newborns were delivered with birth defects. Anomalies of the central nervous system (CNS) were the most 
frequent type of birth defect (43.2%), followed by defects of the musculoskeletal system (19.7%), orofacial 
malformations (11.0%) and gastrointestinal system anomalies (6.1%). Most of the malformed infants were born 
from mothers with a history of alcohol intake (55.8%), lack of iron and folic acid supplementation (58.4%), family 
history of birth defects (58.7%) and history of diseases during pregnancy (53.5%). The outcomes of newborns with 
birth defects were significantly affected by the type of birth defect, gestational age, weight of the newborn and 
presence of twin pregnancy (p-value ≤0.05). 
Conclusions: The prevalence of CNS anomalies was the highest, followed by musculoskeletal system anomalies. 
The type of birth defect, gestational age, weight of newborn and twin pregnancy significantly affected outcomes of 
the newborns with congenital anomalies. Therefore, in order to reduce the prevalence of CMs, the identification 
and management of risk factors should be the focus of stakeholders. Ethiop. J. Health Dev. 2019; 33(3):167-173] 
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Introduction 
A congenital anomaly can originate before birth 
(during intrauterine life) and can be identified 
antenatally, at birth or later in life (1). A congenital 
anomaly interferes with normal body function, with the 
cosmetic appearance of the individual, and may lead to 
infant morbidity or mortality (2-4).  
 
The World Health Organization (WHO) estimates that 
270,000 deaths worldwide (about 7% of all neonatal 
deaths) were caused by birth defects in 2010. Birth 
defects are among the leading causes of childhood 
death, chronic illness, and disability in many countries 
(5). The impact of congenital anomalies is severe in 
middle- and low-income countries – approximately 
95% of children who die from birth defects are from 
such countries (6). 
 
For 50% to 60% of congenital anomalies, the etiology 
is unknown (7). However, risk factors for congenital 
anomalies are multifactorial. They include advanced 
maternal age, prior pregnancy or family history of birth 
defect, consanguinity, maternal disease, alcohol 
drinking, drug intake, viral infection, and exposure to 
ionizing radiation during pregnancy (8). Congenital 
anomalies can be also caused by single gene defects, 
chromosomal disorders, multifactorial inheritance, 
environmental teratogens or micronutrient deficiencies 
(6).  
 
Contrary to the commonly held view that congenital 
disorders are not a public health issue in developing 
countries, in recent years, a number of developing 
countries have experienced an epidemiological 
transition, with significant declines in infant mortality 
rates, reduction of infections and malnutrition, and a 
relative increase in morbidity and mortality due to CMs 
(9). 
  
Congenital anomalies are not only leading causes of 
fetal loss, but also contribute significantly to pre-term 
birth, childhood and adult morbidity, along with 
considerable repercussions on mothers and their 
families (10). 
 
A prevalence study conducted in central and north west 
Ethiopia in Dessie Referral Hospital (DRH), one of the 
present study sites, reported a relatively high 
prevalence of CMs at 1.9% (11).   
 
Objectives 
Congenital anomalies pose a significant impact at 
individual and national level in any given country. 
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Knowing the prevalence and outcomes of congenital 
anomalies is important for planning and implementing 
programs to reduce morbidity and mortality resulting 
from birth defects. The main purpose of this study was 
to estimate the prevalence of birth defects, identify 
their outcomes, and assess the presence of any risk 
factors. In addition, the data generated in this study can 
be used as baseline for further prevalence studies, and 
for planning and implementing appropriate clinical 
management strategies by considering the outcomes of 
birth defects. 
  
Methods and subjects 
Study area and study period: The study was 
conducted in South Wollo and Oromia zones, Amhara 
regional state, from January 2015 to December 2017. 
South Wollo and Oromia zones are found 300-470km 
north east of Addis Ababa. They cover a large area in 
the eastern Amhara Region.  
 
Study design: A retrospective, institution-based, cross-
sectional study design was used. Data were collected 
by reviewing the medical records of mothers to 
describe the prevalence and outcomes of newborns 
with CMs.  
 
Source population: The source population was all 
newborn babies with or without birth defects delivered 
in the health institutions of South Wollo and Oromia 
zones of Amhara regional state.  
 
Study population: The study population was infants 
born with birth defects, during the study period, in 
selected health institutions: Dessie Referral Hospital 
(DRH), Boru Meda Hospital (BMH) and Kemissie 
General Hospital (KGH).  
 
Inclusion and exclusion criteria: Records of mothers 
with malformed infants were included in the study. 
Records of mothers with incomplete information were 
excluded from the study. 
 
Sample size determination: The sample size was all 
the medical records of newborns with CMs in the 
selected hospitals. A total of 324 records of mothers 
with malformed infants were identified and reviewed. 
The records selected were: 252 from DRH, 47 from 
KGH and 25 from BMH. From these 324 medical 
records 14 (11 from DRH and three from KGH) were 
incomplete and were excluded from the study.  
 
Sampling method: Registration books of all births 
attended in the selected study hospitals during the 
study period were screened for CMs and all documents 
of mothers with malformed infants were reviewed and 
used for this study. The study hospitals were selected 
by way of purposive sampling.  
 
Data collection method: Permission to collect data 
was obtained from hospital managers and medical 
directors. The data were collected by trained midwives 
and nurses from medical records using checklists. The 
period of data collection was from January 2018 to 
March 2018.  
 
Dependent variables: Congenital malformations and 
outcomes of newborns.  
 
Independent variables: Socio-demographic factors; 
family history; behavioural factors such as alcohol 
intake, drug usage during pregnancy; exposure to 
teratogenic factors; chronic diseases; iron and folate 
supplementation; and types of CMs. 
 
Data quality control: To maintain the quality of data 
obtained from the documents, checklists were used that 
were pre-tested before actual data collection. The 
documentation of information in the checklists was 
carried out by midwives and nurses who were working 
at the delivery wards.  
 
Data analysis: The data obtained were checked, 
cleaned and entered into SPSS version 23. Descriptive 
analysis (frequency) for types and proportions of birth 
defects was conducted, and risk factors of birth defects 
seen in the mothers were calculated, with a 95% 
confidence interval for outcomes of birth defects. P-
values of ≤0.05 were considered as statistically 
significant. The results were presented in the form of 
text, figures and tables.  
 
Ethical considerations: A support letter was obtained 
from Wollo University College of Medicine and Health 
Sciences and submitted to the authorized personnel of 
the respective health institutions. After obtaining 
permission from medical directors, the health care 
providers were contacted and the aims of the study 
were presented and explained. The patients’ anonymity 
and confidentiality were maintained throughout the 
study period. Patients’ data obtained from each 
document were kept in a locked cabinet. 
 
Results  
A total of 22,624 infants were delivered in DRH, BRH 
and KGH from January 2015 to December 2017. Of 
these newborns, 12,047 (53.25%) were male and 
10,577 (46.75%) were female. Of these, 324 (1.43%) 
were born with congenital malformations (CMs), of 
which 198 (61.1%) were male and 126 (38.9%) were 
female. A total of 14 records (11 from DRH and three 
from KGH) out of 324 were incomplete and were 
excluded from the study; data from 310 
records/documents were then used for analysis. A total 
of 14 infants out of 1,000 births were born with 
congenital anomalies.  
 
As shown in Table 1, the socio-demographics of the 
study subjects showed that there were more male cases 
of birth defects (63.9%) than female (36.1%). The 
majority of infants were born from mothers of rural 
residence (63.2%). Of the infants with CMs, the 
majority (57.7%) of the cases were born from mothers 
whose age was greater than or equal to 35 years and 




Prevalence and outcomes of birth defects in newborns      169 
 
Ethiop. J. Health Dev.2019; 33(3) 
 
Table 1: Socio-demographic characteristics of study subjects in the study hospitals, January 2015 to December 2017 
Characteristics                 Variables  Frequency (n=310) % 
Sex of newborn Male 198 63.9 
Female 112 36.1 
Age of other < 35 years  131 42.3 
>35 years  179 57.7 
Residence  Urban 114 36.8 
Rural 196 63.2 
Occupation  Farmer 129 41.6 
Private employee 79 25.5 
Government employee 90 29.0 
Other  12 3.9 
 
Congenital anomalies pertaining to the central nervous 
system (CNS) accounted for the majority of the cases 
(43.2%) followed by musculoskeletal system defects 
(19.7%), orofacial malformations (11.0%), 
gastrointestinal system anomalies (6.1%), 
genitourinary system defects (4.2%), head and neck 
malformations (3.5%), cardiovascular system defects 
(2.9%) and Down syndrome (2.6%). Twenty-one of the 
cases (6.8%) were not specified in the documents.  
 
Among the infants with CNS anomalies, spina bifida 
was the most common, accounting for 121 (39.0%) of 
the total cases of CMs, followed by hydrocephalus 
(4.2%). Of the musculoskeletal system malformations, 
club foot was the most common, which accounted for 
42 (13.6%) cases followed by 19 omphalocele (6.1%) 
cases. Combined cleft lip and palate (4.9%) was the 
most prevalent orofacial malformation, followed by 
cleft lip (3.2%) and cleft palate (2.9%). Of the 
gastrointestinal anomalies, imperforated anus 
accounted for 11 (3.5%) cases, followed by seven cases 
(2.3%) of infantile hypertrophic pyloric stenosis 
(IHPS) (Table 2). 
 
Table 2: Frequency distribution of congenital malformations in the study hospitals, January 2015 to December 2017 
Body systems  Type of CM Frequency 
(310) 
 % 
Central nervous system  134 43.2 
  Spina bifida 121 39.0 
  Hydrocephalus  13 4.2 
Musculoskeletal system  61 19.7 
  Club foot 42 13.6 
 Omphalocele 19 6.1 
Orofacial anomalies   34 11.0 
  Cleft lip 10 3.2 
 Cleft palate 9 2.9 
 Cleft lip and cleft palate 15 4.9 
Gastrointestinal system  19 6.1 
  Imperforated anus 11 3.5 
 IHPS  7 2.3 
 Other 1 0.3 
Genitourinary system  13 4.2 
Head and neck CMs  11 3.5 
Cardiovascular system  9 2.9 
Down syndrome  8 2.6 
Unspecified  21 6.8 
Total  310 100 
IHPS: infantile hypertrophic pyloric stenosis; CMs: congenital malformations 
 
Among the mothers with malformed infants, 129 
(41.4%) used iron and folic acid supplementation 
during pregnancy, whereas 181 (58.4%) did not. The 
majority of mothers (55.8%) had a history of alcohol 
intake. One hundred and eighty-two (58.7%) of the 
mothers had a family history of birth defects, and about 
166 (53.5%) had diseases during the period of 
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Table 3: Frequency of risk factors of birth defects observed in mothers of malformed infants in the study hospitals, 
January 2015 to December 2017 
Variables Response Frequency (n=310) % 
Iron and folic acid supplementation Yes  129 41.6 
No 181 58.4 
History of alcohol intake Yes  173 55.8 
No 137 44.2 
Family history of BDs Yes  182 58.7 
No 128 41.3 
Disease during the pregnancy Yes  166 53.5 
No 144 46.5 
Medication history during the pregnancy Yes  163 52.6 
No 147 47.4 
Total   310 100 
BDs: Birth defects 
 
Among mothers with a history of disease during 
pregnancy, about 53 (33.13%) had diabetes mellitus 
(DM), followed by hypertension (HPT) (28.92%), 
HIV/AIDS (22.23%), heart problems (7.23%), other 





Figure 1: Types of diseases on mothers of malformed infants during pregnancy in the study hospitals, January 2015 to 
December 2017  
 
Of all the mothers, about 163 (52.6%) used medication 
during the period of pregnancy, while 147 (47.4%) did 
not. Of those mothers with a history of taking 
medication, the majority used antidiabetic (34.4%), 
antihypertension (25.8%), and antiretroviral drugs 
(22.7%), drugs for heart problems (7.3%), and other 
drugs (7.3%) (Table 4). 
 
Table 4: Types of drugs used during pregnancy by mothers of malformed infants in the study hospitals, January 2015 to 
December 2017 
Type of drug  Frequency (n=163) % 
Antidiabetic  56 34.4 
Antihypertensive  42 25.8 
Antimalarial  4 2.5 
Heart disease  12 7.3 
Antiretroviral  37 22.7 
Others 12 7.3 
Total 163 100 
 
In this study, of the total 310 infants with CMs, 104 
(33.5%) infants died. Outcomes of the infants were 
significantly affected by the type of CM, with a linear 
association of 7.92 and p-value of 0.005 Infants with 
malformations of the central nervous system (CNS), 
gastrointestinal system (GIS), cardiovascular system 
(CVS), genitourinary system (GUS), Down syndrome 
(DS) and head and neck died more frequently than 
infants with musculoskeletal and orofacial 
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Table 5: Outcomes of infants and types of birth defect in the study hospitals, January 2015 to December 2017 








  Died  Survived Total       
CNS 47 (35.1%) 87 (64.9%) 134 (100%)       
MS 11 (18%) 50 (82%) 61 (100%)       
Orofacial 4 (11.8%) 30 (88.2%) 34 (100%) 7.92 1 0.005 
CVS 5 (55.6%) 4 (44.4%) 9 (100%)       
GIS 9 (47.4%) 10 (52.6%) 19 (100%)       
DS 4 (50%) 4 (50%) 8 (100%)       
GUS 9 (69.2%) 4 (30.8%) 13 (100%)       
Head and neck 5 (45.5%) 6 (54.5%) 11 (100%)       
Unspecified 10 (47.6%) 11 (52.4%) 21 (100%)       
Total 104 
(33.5%) 
206 (66.5%) 310 
(100%) 
   
CNS: central nervous system; GIS: gastrointestinal system; DS: Down syndrome  
MS: musculoskeletal system; CVS: cardiovascular system; GUS: genitourinary system  
 
Gestational age, weight of the newborn and presence of 
twin pregnancy also significantly affected the outcome of 
newborns, with Pearson chi square values of 3.744, 
21.647 and 12.741, and p-values of 0.036, 0.001 and 
0.001, respectively. Malformed infants born under 37 
weeks of gestational age, below 2.5kg body weight and 
with twin pregnancy died more often than expected 
(Table 6). 
 
Table 6: Outcomes of infants with congenital malformations in relation to gestational age, weight and twin pregnancy in 
the study hospitals, January 2015 to December 2017 
 Variables    Outcome of malformed infants   Chi square Df  p-value 
  Died  Survived Total     
GA (weeks) <37 40 (41.2%) 57 (58.8%) 97 (100%)  3.744 1 0.036 
≥37  64 (30%) 149 (70%) 213 (100%) 
Birth weight 
(kg) 
<2.5 31 (62%) 19 (38%) 50 (100%) 21.647 1 0.001 
≥2.5 73 (28.1%) 187 (71.9%) 260 (100%) 
Twin 
pregnancy  
Yes 15 (68.2%) 7 (31.8%) 22 (100%) 12.741 1  0.001  
No 89 (30.9%) 199 (69.1%) 288 (100%) 
Total   104 (33.5%) 206 (66.5%) 310 (100%) 
 
Discussion 
The prevalence and types of CMs differ from one 
country to another and even in the same country from 
one region to another (12).  
 
In the present study, attempts have been made to find 
the prevalence of CMs, maternal risk factors observed 
and their outcomes in hospital deliveries.  
 
The prevalence of CMs in this study was found to be 
higher than that reported in a study conducted in India 
(1.25%) (1). However, the prevalence of CMs in the 
current investigation was slightly lower than the 
prevalence reported by studies conducted in central and 
north west Ethiopia (1.9%), India (1.53%), Egypt (2%), 
and Brazil (2.2%) (11-14). Cohort studies with follow-
up programs indicate a higher incidence of CMs than 
document-based retrospective studies, because they 
allow the collection of valid information on CMs 
which are manifested later in life (15).  
 
The relatively lower prevalence of CMs in this study 
may have been because of the relatively small sample 
size used as well as missing data on CMs that could be 
manifested later in life.  
 
In the present investigation, male infants appeared to 
be more affected by CMs than female infants. This 
observation agrees with the findings of a study 
conducted in western Ethiopia that showed the majority 
of CMs cases were male children (58.5%) (11).  
 
Congenital anomalies affecting the CNS were the most 
common BDs observed in this study. This finding is 
similar to studies conducted in Tanzania, Brazil, other 
areas of Ethiopia, and Egypt (2,13,16,17). A relatively 
high prevalence of congenital CNS anomalies was 
reported by studies in Tanzania (29.8%) (2), Brazil 
(32.6%) (13), and Egypt (32.1%) (17).  In the present 
study, the prevalence of congenital anomalies affecting 
the CNS was relatively high. This may be due to the 
fact that DRH and KGH are among the hospitals in 
South Wollo and Oromia zones which have many 
referral linkages with other hospitals and health 
centers, and receive most of the pregnancies with 
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suspected difficulties and abnormalities. A much 
higher prevalence of anomalies of the CNS was 
reported in a prospective cohort study conducted in 
northern Ethiopia (68.8%) (16).  
 
In the present study, following CNS anomalies, 
musculoskeletal system, orofacial, gastrointestinal 
system and genitourinary system anomalies had the 
highest frequencies, respectively. Similar observations 
have been reported by other studies, where CNS 
anomalies (48%) were the most prevalent, followed by 
anomalies of the musculoskeletal system (18,19). 
However, there are other investigations that contradict 
the findings of our study. In one such study, it was 
reported that the most prevalent congenital anomalies 
were observed in the digestive system, which 
accounted for the maximum number of anomalies of all 
cases (20). The discrepancy of results may be 
explained by differences in methodology used. In the 
present study, a retrospective, document review-based 
approach was used, whereas in other studies, a 
prospective descriptive study design was employed. A 
prospective study design allows collection of 
information of CMs which is manifested later. 
Moreover, most CMs (such as CMs of the heart, GIS, 
respiratory and GUS structures) may not be visible 
externally on the bodies of newborn infants.  
 
The most prevalent CM of the CNS, in this study, was 
spina bifida. This finding agrees with the findings of 
studies conducted in central and western Ethiopia (11), 
as well as in Mekelle and Ayider hospitals (16), which 
reported that the most prevalent congenital anomaly of 
the CNS was spina bifida (51.5% and 70%, 
respectively). The prevalence of spina bifida is much 
higher in these two studies compared to that of our 
study, especially in the study conducted in Mekelle and 
Ayider hospitals. This may be due to the limitations of 
a retrospective study compared to a prospective study. 
The present study was a retrospective study, whereas 
the study in Mekelle and Ayider hospitals was a 
prospective study. In the present study, there may be 
instances of misdiagnosis or failure of health care 
professionals to carefully document the spina bifida 
cases.  
 
In this study, club foot had the highest prevalence of 
cases with musculoskeletal anomalies, while cleft lip 
and palate were highly prevalent in the cases with 
orofacial malformations. These findings are consistent 
with the level of prevalence reported by another similar 
study (17). However, compared to our finding, a much 
higher prevalence of orofacial malformations has been 
reported in a study that was carried out in central and 
western Ethiopia (11). This discrepancy in the 
observed prevalence of orofacial malformations may 
have been due to the difference in the sample size used 
and difference in the duration of the study period. In 
the study conducted in central and western Ethiopia 
(11), the sample size was much larger compared to that 
of our study. Moreover, n the study conducted in 
central and western Ethiopia, data were collected from 
referral hospitals for surgical corrections of 
malformations and the duration of the study period was 
five years compared to that of ours, which was three 
years.  
 
In this study, the frequency of risk factors associated 
with the prevalence of CM were analyzed using 
descriptive statistics. The factors identified as risk 
factors were maternal age above 35 years, lack of iron 
and folic acid supplementation, a history of alcohol 
intake, and a family history of birth defects. In this 
study, it was observed that the majority of mothers 
were exposed to risk factors of birth defects. In the 
present study, the level of correlations between risk 
factors and prevalence of CMs was not assessed, as the 
focus of the study was the prevalence of CMs in 
newborns, relative distribution of BDs in relation to the 
body systems, and identification of outcomes and 
presence or absence of risk factors related to CMs.  
 
The mortality rate of the newborns with birth defects 
was relatively high in the present study compared to 
that reported by a study conducted in Egypt (20). The 
outcomes of infants with birth defects were 
significantly affected by the types of congenital 
anomalies. Infants with CNS, GIS, CVS, GUS, Down 
syndrome and head and neck malformations died more 
than expected, whereas infants with musculoskeletal 
and orofacial malformations died less than expected. 
This finding is in line with published data of studies 
conducted in England and Wales, and in Brazil (21,22).  
 
Conclusions 
In this study, the prevalence of birth defects in 
newborn infants has been observed to be relatively 
high, and female infants were less likely to have birth 
defects compared to male infants. Of all systems of the 
body, the CNS was the most affected, followed by the 
musculoskeletal system. Maternal age above or equal 
to 35 years, lack of iron and folic acid supplementation, 
history of alcohol intake and history of diseases and 
drug usage during pregnancy were the risk factors 
observed in the mothers of malformed infants. The 
outcomes of the newborns with congenital anomalies 
were affected by type of birth defect and presence of 
twin pregnancy. This information gives insight to 
health care providers to help them plan and implement 
appropriate preventive, curative and rehabilitative 
management strategies, depending on the type of CM.  
 
Limitations of the study 
The strength of the present study was the concern given 
to investigate outcomes of birth defects that provide 
information in the study settings that have limited 
research possibilities and coverage in the country. In 
the present study, because we used a retrospective 
study approach, getting complete information and 
avoiding biases were challenging. In addition, there 
was no control group to evaluate the association of risk 
factors with birth defects. 
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